ATEC Stock - Alphatec Holdings, Inc.
Unlock GoAI Insights for ATEC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $611.56M | $482.26M | $350.87M | $243.21M | $144.86M |
| Gross Profit | $424.26M | $310.20M | $233.06M | $157.76M | $102.50M |
| Gross Margin | 69.4% | 64.3% | 66.4% | 64.9% | 70.8% |
| Operating Income | $-136,169,000 | $-173,395,000 | $-146,975,000 | $-128,057,000 | $-58,863,000 |
| Net Income | $-162,123,000 | $-186,638,000 | $-151,293,000 | $-143,032,000 | $-78,994,000 |
| Net Margin | -26.5% | -38.7% | -43.1% | -58.8% | -54.5% |
| EPS | $-1.13 | $-1.54 | $-1.47 | $-1.50 | $-1.18 |
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 28th 2025 | Stifel | Resumed | Buy | $20 |
| October 24th 2025 | JP Morgan | Initiation | Overweight | $19 |
| June 16th 2025 | Lake Street | Resumed | Buy | $18 |
| August 1st 2024 | Morgan Stanley | Downgrade | Equal Weight | - |
| July 8th 2024 | Barclays | Initiation | Overweight | $19 |
| February 9th 2024 | Wells Fargo | Initiation | Overweight | $26 |
| December 19th 2023 | Needham | Reiterated | Buy | $18← $16 |
| October 20th 2023 | ROTH MKM | Initiation | Buy | $22 |
| October 12th 2022 | Jefferies | Initiation | Buy | $12 |
| September 12th 2022 | Morgan Stanley | Initiation | Overweight | $13 |
Earnings History & Surprises
ATECEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 25, 2026 | $0.05 | — | — | — |
Q4 2025 | Oct 30, 2025 | $-0.03 | $0.03 | +200.0% | ✓ BEAT |
Q3 2025 | Jul 31, 2025 | $-0.06 | $0.02 | +133.3% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $-0.12 | $-0.23 | -91.7% | ✗ MISS |
Q1 2025 | Feb 26, 2025 | $-0.19 | $-0.23 | -21.1% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $-0.27 | $-0.28 | -3.7% | ✗ MISS |
Q3 2024 | Jul 31, 2024 | $-0.26 | $-0.29 | -11.5% | ✗ MISS |
Q2 2024 | May 7, 2024 | $-0.33 | $-0.34 | -3.0% | ✗ MISS |
Q1 2024 | Feb 27, 2024 | $-0.28 | $-0.37 | -32.1% | ✗ MISS |
Q4 2023 | Nov 6, 2023 | $-0.30 | $-0.35 | -16.7% | ✗ MISS |
Q3 2023 | Aug 3, 2023 | $-0.30 | $-0.43 | -43.3% | ✗ MISS |
Q2 2023 | May 4, 2023 | $-0.32 | $-0.40 | -25.0% | ✗ MISS |
Q1 2023 | Feb 28, 2023 | $-0.30 | $-0.33 | -10.0% | ✗ MISS |
Q4 2022 | Nov 3, 2022 | $-0.32 | $-0.35 | -9.4% | ✗ MISS |
Q3 2022 | Aug 4, 2022 | $-0.35 | $-0.36 | -2.9% | ✗ MISS |
Q2 2022 | May 5, 2022 | $-0.29 | $-0.43 | -48.3% | ✗ MISS |
Q1 2022 | Mar 1, 2022 | $-0.31 | $-0.40 | -29.0% | ✗ MISS |
Q4 2021 | Nov 4, 2021 | $-0.23 | $-0.43 | -87.0% | ✗ MISS |
Q3 2021 | Aug 3, 2021 | $-0.20 | $-0.30 | -50.0% | ✗ MISS |
Q2 2021 | May 6, 2021 | $-0.19 | $-0.16 | +15.8% | ✓ BEAT |
Latest News
Freedom Capital Markets Initiates Coverage On Alphatec Holdings with Buy Rating, Announces Price Target of $25
📈 PositiveMorgan Stanley Maintains Equal-Weight on Alphatec Holdings, Raises Price Target to $21
📈 PositiveBarclays Maintains Overweight on Alphatec Holdings, Raises Price Target to $23
📈 PositiveCanaccord Genuity Maintains Buy on Alphatec Holdings, Raises Price Target to $25
📈 PositivePiper Sandler Reiterates Overweight on Alphatec Holdings, Raises Price Target to $25
📈 PositiveStifel Maintains Buy on Alphatec Holdings, Raises Price Target to $24
📈 PositiveAlphatec Holdings shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates. Also, HC Wainwright and Needham raised their respective price targets on the stock.
📈 PositiveHC Wainwright & Co. Maintains Buy on Alphatec Holdings, Raises Price Target to $24
📈 PositiveNeedham Maintains Buy on Alphatec Holdings, Raises Price Target to $22
📈 PositiveAlphatec Holdings shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates.
📈 PositiveAlphatec Holdings Raises FY2025 Sales Guidance from $742.000M to $760.000M vs $742.037M Est
📈 PositiveAlphatec Holdings Q3 2025 Adj. EPS $0.03 Beats $(0.14) Estimate, Sales $196.503M Beat $182.632M Estimate
📈 PositiveStifel Reinstates Buy on Alphatec Holdings, Announces $20 Price Target
📈 PositiveJP Morgan Initiates Coverage On Alphatec Holdings with Overweight Rating, Announces Price Target of $19
📈 PositiveWells Fargo Maintains Overweight on Alphatec Holdings, Raises Price Target to $16
📈 PositiveAlphatec GAAP EPS of -$0.27 misses by $0.08, revenue of $185.54M beats by $6.69M
➖ NeutralFrequently Asked Questions about ATEC
What is ATEC's current stock price?
What is the analyst price target for ATEC?
What sector is Alphatec Holdings, Inc. in?
What is ATEC's market cap?
Does ATEC pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ATEC for comparison